Erkrath, Germany

Zbigniew Janowicz

USPTO Granted Patents = 1 


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Zbigniew Janowicz: A Pioneer in DNA Research

Introduction

Zbigniew Janowicz, based in Erkrath, Germany, is an accomplished inventor known for his contributions to genetic engineering. He holds a significant patent that has implications for biotechnology and molecular biology.

Latest Patents

Janowicz's notable patent focuses on DNA-molecules coding for formate dehydrogenase (FMDH) control regions and the structural gene related to this enzyme. This invention encompasses DNA sequences that encode control regions and a structural gene essential for producing a protein with FMDH activity. Moreover, these DNA-molecules can be combined with foreign gene sequences, placing these genes under the strict control of FMDH regulatory sequences. The invention also includes recombinant vectors containing these DNA-molecules and microorganisms that incorporate such vectors or DNA-molecules. Additionally, the process involves culturing these microorganisms to produce and recover valuable substances, making it a significant advancement in the field.

Career Highlights

Janowicz currently works at Rhein Biotech, where he utilizes his expertise in genetic research and innovation. His career reflects a commitment to advancing biotechnology through practical applications of DNA manipulation and recombinant technology.

Collaborations

Throughout his career, Janowicz has collaborated with notable colleagues, including Cornelius P. Hollenberg, to enhance research initiatives and drive forward-thinking projects within the biotechnology sector.

Conclusion

Zbigniew Janowicz's contributions to the field of molecular biology and biotechnology through his innovative patent highlight the intersection of research and practical application. His work at Rhein Biotech serves as a testament to the potential of DNA technology in producing useful substances, underscoring the importance of continued innovation in this rapidly evolving field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…